SCREENING FOR DIABETIC RETINOPATHY: A COMPARATIVE STUDY BETWEEN HOSPITAL AND COMMUNITY BASED SCREENING AND BETWEEN PAYING AND NON-PAYING PATIENTS

Authors

  • Tayyab Afghani
  • Nadeem Qureshi
  • Khalid Saeed Ahmad Chaudhry

Abstract

Background: Prevalence of diabetes and diabetic retinopathy varies in the population consideringthe background and financial status. Methods: A total of 79,194 people more than 40 years, werescreened for diabetes both in the community and eye hospital setting. Initial screening was carriedout by urine dipstick followed by random blood sugar examination. A value ³ 140 mg/dl of bloodsugar was considered positive for diabetes. All the diabetics were then examined for any evidenceof diabetic retinopathy through indirect ophthalmoscopy in a dilated pupil by a midlevelophthalmologist. Health education campaign at public, patient and professional level was alsoconducted. Results: The results of screening were analyzed for three distinct groups; ruralpopulation, hospital based free patients and hospital based paying patients. The prevalence ofdiabetes was found to be 9.12%, 10.34% and 18.57% in rural community, poor hospital andaffluent hospital groups respectively. The prevalence of diabetic retinopathy in the total screenedpopulation in these three subgroups was 1.92%, 2.52% and 4.42% respectively, while thisprevalence in the diabetic population was 21.05%, 24.39% and 23.80% respectively. The cost perperson screened was $2.6-3.4, while the cost per diabetic identified was $26-28 and the cost perpatient of diabetic retinopathy identified was $ 108-135. Conclusion; The prevalence of diabeticretinopathy was two times more in the affluent hospital patients as compared to poor hospitalpatients or rural population. For each known diabetic, there were four previously undiscovereddiabetics in the rural population, and two previously undiscovered diabetics in hospital basedpopulation.Key words: Diabetes Mellitus, Diabetic Retinopathy, Health Education.

References

Wild S, Roglic G, Green A, Sicree R, King H. Global

Prevalence of Diabetes; Estimates for the year 2000 and

projections for 2030. Diabet Care 2004; 27:1047-53.

Engelgau MM, Narayan KM, Herman WH. Screening for type

diabetes. Diabet Care 2000; 23:1563-80.

Akhtar J. The Burden of Diabetes in Pakistan: The National

Diabetes Survey (Editorial). J Pak Med Assoc 1999; 49: 205-6.

Harris MI. Undiagnosed NIDDM: clinical and public health

issues. Diabet es Care 1993;16: 642-52.

Reckless JPD. The epidemiology of heart disease in diabetes

mellitus. In: Taylor KG, ed. Diabetes and the Heart . Tunbridge

Wells, UK. Castle House Publications 1987:1 -18.

Economic consequences of diabetes mellitus in the U.S. in

American Diabetes Association.

Diabetes Care. 1998 Feb;21(2):296-309.

Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of

NIDDM occurs at least 4 -7 years before clinical diagnosis.

Diabet es Care 1992;15(7):815-19.

Diabetes United Kingdom. Audit shows 10-year delay in

diagnosing type 2 diabetes. Diabetes Update 2000; Winter:1

Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA,

Riccardi G. Risk of diabetes in the new diagnostic category of

impaired fasting glucose: a prospective analysis. Diabet es Care

;22(9):1490-93.

Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin

GE, Eschwege E. Risk factors for NIDDM in white population.

Paris prospective study. Diabet es 1991;40(7):796-99.

Hulley SB, Grady D, Browner WS. Statins: underused by those

who would benefit . BMJ 2000;321:971-72.

Patchett P, Roberts D. Diabetic patients who d o not have

diabetes: investigation of register of diabetic patients in general

practice. BMJ 1994;308:1225-26.

Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes?

Evaluation against National Screening Committee criteria. BMJ

;322:986-88.

Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for

diabetic retinopathy. Ann Intern Med 1992; 116:660-71.

Ferris FL 3rd. How effective are treatments for diabetic

retinopathy? JAMA 1993;269:1290-1.

Rohan TE, Frost CD, Wald NJ. Prevention of blindness by

screening for diabetic retinopathy: a quantitative assessment.

BMJ 1989; 299: 1198-1201.

Kohner EM. Diabetic retinopathy. BMJ 1993; 307:1195-9.

Hawthorne K, Mello M, Tomlinson S. Cultural and religious

influences in diabetes care in Great Britain. Diabet Med 1993;

(1): 8-12.

Unwin N, Alberti KG, Bhopal R, Harland J, Watson W, White

M. Comparison of the current WHO and new ADA criteria for

the diagnosis of diabetes mellitus in three ethnic groups in the

UK. Diabet Med 1998; 15(7):554-7.

Riste L, Khan F, Cruickshank K. High prevalence of type 2

diabetes in all ethnic groups, including Europeans, in a British

inner city: relative poverty, history, inactivity, or 21st century

Europe? Diabetes Care 2001; 24(8): 1377-83.

Abate N, Chandalia M. Ethnicity and type 2 Diabetes: focus on

Asian Indians. J Diabetes Complications. 2001; 15(6):320-7.

Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein

MC. Evaluating the cost -effectiveness of clinical and public

health measures. Annu Rev Public Health. 1998;19:125-52.

Lawrence JM, Bennett P, Young A, Robinson AM. Screening

for diabetes in general practice: cross sectional population

study. BMJ 2001; 323: 548-51.

Selby JV, Ray GT, Zhang D, Colby CJ. Excess costsof medical

care for patients with diabetes in a managed care population.

Diabet es Care. 1997;20(9):1396-1402.

Gilmer TP, O’Connor PJ, Manning WG, Rush WA. The cost

to health plans of poor glycemic control.. Diabetes Care

;20(12):1847-53.

Lawrence J, Robinson A. Screening for Diabetes in General

Practice. Prev Cardiol 2003; 6(2):78-84.

Modan M, Harris MI. Fasting plasma glucose in screening for

NIDDM in the U.S and Israel. Diabet es Care. 1994;17(5):436-

Is fasting glucose sufficient to define diabetes? Epidemiological

data from 20 European studies. The DECODE- study group.

European Diabetes Epidemiology Group. Diabetes

Epidemiology: Collaborative analysis of Diagnostic criteria in

Europe. Diabetologia. 1999;42(6): 647-54.

Bourn D, Mann J. Screening for noninsulin dependent diabetes

mellitus and impaired glucose tolerance. N Z Med J

;105(943):208-210.

Davies MJ, Williams DR, Metcalfe J, Day JL. Community

screening for non-insulin-dependent diabetes mellitus: selftesting for postprandial glycosuria. Q J Med. 1993;86(10):677-

Anderson DK, Lundblad E, Svardsudd K. A model for early

diagnosis of type 2 diabetes mellitus in primary health care.

Diabet Med 1993;10(2):167-73.

Basit A, Hydrie MZ, Ahmed K, Hakeem R. Prevalence of

diabetes, impaired fasting glucose and associated risk factors in

J Ayub Med Coll Abbottabad 2007; 19(1)

a rural area of Baluchistan province according to new ADA

criteria. J Pak Med Assoc 2002; 52: 357-60.

Shera A, Rafique G, Khawaja I, Baqai S, Khan I, King H, et al.

Pakistan National Diabetes Survey prevalence of glucose

intolerance and associated factors in North West at Frontier

Province (NWFP) of Pakistan. J Pak Med Assoc 1999; 49(9):

-11.

Shera AS, Rafique G, Khawaja IA, Baqai S, King H. Pakistan

National Diabetes Survey: prevalence of glucose intolerance

and associated factors in Baluchistan province. Diabet es Res

Clin Practice. 1999; 44(1); 49-58.

Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H.

Pakistan national diabetes survey: prevalence of glucose

intolerance and associated factors in Shikarpur, Sindh Province.

Diabet Med 1995; 12(12): 1116-21.

Hameed K, Kadir M, Gibson T, Sultana S, Fatima Z, Syed A.

The frequency of known diabetes, hypertension and ischaemic

heart disease in affluent and poor urban populations of Karachi,

Pakistan. Diabet Med. 1995;12:500-3.

Simmons D, Williams DR, Powell MJ. Prevalence of diabetes

in different regional and religious south Asian communities in

Coventry. Diabet Med. 1992;9(5): 428-31.

Evans J. Causes of blindness and partial sight in England and

Wales 1990-91. In studies on medical and population subjects

no 57 HMSO. 1995

Drummond MF, Davies LM, Ferris FL. Assessing the costs

and benefits of medical research: the diabetic retinopathy study.

Soc Sci Med. 1992 ; 34(9) : 973-81.

Bachmann MO, Nelson SJ. Impact of diabetic retinopathy

screening on a British district population: case detection and

blindness prevention in an evidence-based model. J Epidemiol

Community Health 1998;52(1):45-52.

Zambarakji HJ, Butler TK, Vernon SA. Assessment of

Heidelberg Retinal Tomograph in the detection of sightthreatening diabetic maculopathy. Eye 1999; 13(Pt 2): 136-44.

Martin JD, Yidegiligne HM. The cost-effectiveness of a retinal

photography screening program for preventing diabetic

retinopathy in the First Nations diabetic population in British

Columbia, Canada. Int J Circumpolar Health. 1998; 57(Suppl

:379-82.

Kleinstein RN, Roseman JM, Herman WH, Holcombe J, Louv

WC. Detection of diabetic retinopathy by optometrists. J Am

Optom Assoc. 1987;58(11):879-82.

Namperumalsamy P, Nirmalan PK, Ramasamy K. Developing

a screening program to detect sight-threatening diabetic

retinopathy in South India. Diabetes Care. 2003;26(6):1831-5.

Garvican L, Clowes J, Gillow T. Preservation of sight in

diabetes: developing a national risk reduction programme.

Diabet Med. 2000; 17(9):627-34.

Haider Z, Obaidullah S. Clinical diabetes mellitus in Pakistan. J

Trop Med Hyg. 1981; 84(4): 155-58.

Khan AJ. Prevalence of diabetic retinopathy in Pakistani

subjects. A pilot study. J Pak Med Assoc. 1991; 41(3): 49-50.

Fernando DJ, Siribaddana S, De Silva, Subasinge Z. Prevalence

of retinopathy in a Sri Lankan diabetes clinic. Ceylon Med J.

; 38(3):120-3.

Younis N, Broadbent DM, Harding SP, Vora JR. Prevalence of

diabetic eye disease in patients entering a systematic primary

care-based eye screening programme. Diabet Med 2002;

(12): 1014-21.

Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R,

Moss SE, et al. The prevalence of diabetic retinopathy among

adults in the United States. Arch Ophthalmol. 2004;122(4):552-

Rajala U, Laakso M, Qiao Q, Keinanen-Kiukaanniemi S .

Prevalence of retinopathy in people with diabetes, impaired

glucose tolerance, and normal glucose tolerance. Diabet es Care.

;21(10):1664-9.

Maberley DA, Koushik A, Cruess AF. Factors associated with

missed eye examinations in a cohort with diabetes. Can J Public

Health. 2002; 9(3):229-32.

Newcomb PA, Klein R. Factors associated with compliance

following diabetic eye screening. J Diabet Complications 1990;

(1): 8-14.

Jabbar A, Contractor Z, Ebrahim MA, Mahmood K. Standard

of knowledge about their disease among patients with diabetes

in Karachi, Pakistan. J Pak Med Assoc 2001; 51:216-8.

Ali M, Khalid GH, Pirkani GS. Level of health education in

patients with type II diabetes mellitus in Quetta. J Pak Med

Assoc. 1998; 48(11): 334-6.

Habib SS, Aslam M. Risk factors, knowledge and health status

in diabetic patients. Saudi Med J 2003;24:1219-24.

Hawthorne K, Tomlinson S. Pakistani moslems with Type 2

diabetes mellitus: effect of sex, literacy skills, known diabetic

complications and place of care on diabetic knowledge,

reported self-monitoring management and glycaemic control.

Diabet Med 1999; 16(7): 591-7.

Eiser JR, Eiser C, Riazi A, Taylor DJ, Hammersley S, Tooke

JE. Screening for diabetic retinopathy is well received by

patients and may improve self-management intentions. Diabet

Med. 2001;18(10): 835-41.

Shera AS, Jawad F, Basit A. Diabetes related knowledge,

attitude and practices of family physicians in Pakistan. J Pak

Med Assoc 2002; 52(10): 465-70.

Awh CC, Cupples HP, Javitt JC. Improved detection and

referral of patients with diabetic retinopathy by primary care

physicians. Effectiveness of education. Arch Intern Med 1991;

(7): 1405-8.

Downloads

Published

2007-03-01